BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21144483)

  • 21. Intranasal absorption of oxymorphone.
    Hussain MA; Aungst BJ
    J Pharm Sci; 1997 Aug; 86(8):975-6. PubMed ID: 9269879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravail: highly effective intranasal delivery of peptide and protein drugs.
    Maggio ET
    Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.
    Borland M; Jacobs I; King B; O'Brien D
    Ann Emerg Med; 2007 Mar; 49(3):335-40. PubMed ID: 17067720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer pain.
    Bulloch MN; Hutchison AM
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):9-22. PubMed ID: 23272789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An experimental study on nasal absorption of gentamycin in dogs.
    Wang JQ; Bu GX
    Chin Med J (Engl); 1994 Mar; 107(3):219-21. PubMed ID: 8088184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent development in therapeutics for breakthrough pain.
    Davis MP
    Expert Rev Neurother; 2010 May; 10(5):757-73. PubMed ID: 20420495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equivalency of two concentrations of fentanyl administered by the intranasal route for acute analgesia in children in a paediatric emergency department: a randomized controlled trial.
    Borland M; Milsom S; Esson A
    Emerg Med Australas; 2011 Apr; 23(2):202-8. PubMed ID: 21489168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
    Marttin E; Verhoef JC; Merkus FW
    J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New strategies to improve the intranasal absorption of insulin.
    Duan X; Mao S
    Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The application of mucoadhesive polymers in nasal drug delivery.
    Jiang L; Gao L; Wang X; Tang L; Ma J
    Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal route: an alternative approach for antiemetic drug delivery.
    Ozsoy Y; Güngör S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1439-53. PubMed ID: 22004793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rectal insertion of fentanyl patches: a new route of toxicity.
    Coon TP; Miller M; Kaylor D; Jones-Spangle K
    Ann Emerg Med; 2005 Nov; 46(5):473. PubMed ID: 16271683
    [No Abstract]   [Full Text] [Related]  

  • 33. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.
    Ugwoke MI; Agu RU; Verbeke N; Kinget R
    Adv Drug Deliv Rev; 2005 Nov; 57(11):1640-65. PubMed ID: 16182408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain relief.
    Toussaint S; Maidl J; Schwagmeier R; Striebel HW
    Can J Anaesth; 2000 Apr; 47(4):299-302. PubMed ID: 10764171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal therapeutic fentanyl-system (TTS-F).
    Mystakidou K; Katsouda E; Tsilika E; Parpa E; Vlahos L
    In Vivo; 2004; 18(5):633-42. PubMed ID: 15523905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of break-through pain].
    Krankenpfl J; 2004; 42(3-4):89. PubMed ID: 15311891
    [No Abstract]   [Full Text] [Related]  

  • 37. Intranasal fentanyl in 1-3-year-olds: a prospective study of the effectiveness of intranasal fentanyl as acute analgesia.
    Cole J; Shepherd M; Young P
    Emerg Med Australas; 2009 Oct; 21(5):395-400. PubMed ID: 19840089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits.
    Al-Ghananeem AM; Malkawi AH; Crooks PA
    Drug Dev Ind Pharm; 2011 Mar; 37(3):329-34. PubMed ID: 21244195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fentanyl intranasal. Breakthrough cancer pain: unsafe packaging.
    Prescrire Int; 2010 Nov; 19(110):251. PubMed ID: 21284356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.